Navigation Links
World Congress on Industrial Biotechnology: Germany Home to Top Biotech Research and Investment
Date:4/25/2008

BERLIN, April 25 /PRNewswire/ -- Processes and products based on biomass and industrial biotechnology offer significant business potential for the chemical industry in a wide range of applications such as bioplastics. A panel on developments in the field of industrial biotechnology in Germany will be held at the World Congress on Industrial Biotechnology and Bioprocessing (April 27-30, 2008) in Chicago, Illinois. The panel runs from 10:45am to 12:15pm on April 28th at the Hilton Chicago, 720 South Michigan Ave.

Research institutes play a pivotal role in biotechnology investments, and they are particularly strong in Germany as the country has many internationally recognized research centers. Dr. Steffen Rupp is the Head of Molecular Biotechnology of Fraunhofer IGB at the Fraunhofer Campus Stuttgart. His laboratory is a part of the wider network of Fraunhofer Institutes, a world-renowned research organization with affiliate centers all over Germany. He will discuss renewable feedstock such as residual biomass and ways of transforming such biomass into practical energy sources.

Chemical parks are a major attraction to Germany for the chemicals and biotechnology industries. Dr. Markus Wolperdinger is in charge of industrial biotech activities at InfraLeuna GmbH. InfraLeuna is the owner and infrastructure provider of one of Germany's largest chemical sites. The Leuna chemical site is home to over 100 companies, including some of the world's top chemical companies. Dr. Wolperdinger will discuss activities in the industrial biotechnology field that are currently taking place at the Leuna chemical site.

Dr. Karin Bronnenmeier will discuss the transfer of knowledge from fossil based refineries to future biorefineries. Specifically the integration of biotech expertise from biopharma biotech will be the focus of her presentation. She is the "know-how" manager for Biotechnology Plants at Linde-KCA-Dresden, the Competence Center Biotechnology at Linde's engineering division. The Linde Group is a leading gases and engineering company with 50,000 employees in over 70 countries.

Germany has the largest market in Europe for both the chemical industry and thermoplastics. The panel will address investment possibilities in Germany in a diversity of sectors, such as biotechnology and bioplastic.

Invest in Germany is the inward investment promotion agency of the Federal Republic of Germany. It provides investors with comprehensive support from site selection to the implementation of investment decisions.

Media Contact:

Eva Henkel

Invest in Germany

Phone: +49-30-200099-173

Fax: +49-30-200099-111

Email: henkel@invest-in-germany.com

http://www.invest-in-germany.com


'/>"/>
SOURCE Invest in Germany
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. GlaxoSmithKline to Acquire Sirtris Pharmaceuticals, a World Leader in Sirtuin Research and Development
2. febit to Introduce Geniom RT Analyzer(R) to U.S. Market at RNAi World Congress
3. Novavax CEO to Present at the World Vaccine Congress 2008
4. BIOTECON Diagnostics and MERCK KGaA start worldwide marketing alliance
5. Graphene used to create worlds smallest transistor
6. BioSpace and IBC Life Sciences Announce Career Fair Alliance For Drug Discovery & Development of Innovative Therapeutics World Congress
7. Researchers create the first thermal nanomotor in the world
8. WorldHeart 10-KSB Audit Report Includes Going Concern Qualification
9. Real-World Data from ARRIVE Registries Show Favorable Outcomes for TAXUS(R) Express(TM) Stent
10. CyberKnife Radiosurgery Used to Treat Lung Tumors at 90 Percent of Centers Worldwide
11. Schiller AG Adopts Masimo Rainbow SET as Their Technology Platform of Choice for Patient Monitoring Devices Worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Diego, CA (PRWEB) , ... June 27, 2016 , ... ... solutions for clinical trials, announced today the Clinical Reach Virtual Patient Encounter ... their care circle with the physician and clinical trial team. , Using the CONSULT ...
(Date:6/27/2016)... 27, 2016  Liquid Biotech USA ... of a Sponsored Research Agreement with The University ... (CTCs) from cancer patients.  The funding will be ... correlate with clinical outcomes in cancer patients undergoing ... then be employed to support the design of ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a ... eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research ... by providing practical tips, tools, and strategies for clinical researchers. , “The landscape ...
Breaking Biology Technology:
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
(Date:4/26/2016)... and LONDON , April ... part of EdgeVerve Systems, a product subsidiary of ... today announced a partnership to integrate the Onegini ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... their customers enhanced security to access and transact ...
(Date:4/14/2016)... Israel , April 14, 2016 ... Authentication and Malware Detection, today announced the appointment of ... assumed the new role. Goldwerger,s leadership appointment ... on the heels of the deployment of its platform ... BioCatch,s behavioral biometric technology, which discerns unique cognitive and ...
Breaking Biology News(10 mins):